Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Humana: Private Insurers Succeeding With Medical Home, ACO Models

This article was originally published in The Gray Sheet

Executive Summary

Government health care reform efforts involving accountable-care organizations and medical home models are still being finalized. But insurer Humana has already proven the promise of both concepts to enhance care quality and reduce costs, argues CEO Mike McCallister.

You may also be interested in...



Mobile Devices For Blood Pressure Checks Highlighted In Heart Campaign

Public-private “Million Hearts” campaign to reduce the heart attack and stroke rate by one million by 2017 will emphasize mobile technology for monitoring blood pressure.

CMS Officials Tackling Widespread Concerns Over ACO Regulations

CMS officials last week acknowledged the challenges health care industry stakeholders face in embracing accountable care organizations while federal regulations governing the program are still in flux.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030346

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel